IL17A and psoriasis: Liposome gel showed stronger efficacy, which may be due to the enhancement of the permeability, which allows the drug to reach the dermis of psoriasis skin to reduce the chemotactic activity of inflammatory cells (mononuclear and neutrophils) and the expression of inflammatory factors (such as IL-17 and IL-22) (Ternowitz, 1987).